Research Papers

25 of 824 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in …
Zeng J; Funk J; Lee BR; Hsu CH; Messing EM; Chipollini J.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper …
Yuan C; Xu C; Li Z; Meng C; Du Y; Zhang C; Fang D; Li X; Zhou L.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Kidney stones are associated with metabolic syndrome in a health screening population: a cross-sectional study.
Chen L; Zhang J; Shen K; Zhu Y; Zhang J; Pan J; Chen L.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The use of low-intensity extracorporeal shockwave therapy in management of erectile dysfunction following prostate canc…
Matthew AN; Rogers DE; Grob G; Blottner M; Kodama S; Krzastek SC.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Initial experience and short-term outcomes of single-port extraperitoneal transvesical robot-assisted radical prostatec…
Zhou X; Deng W; Li Z; Zhang C; Liu W; Guo J; Chen L; Huang W; Lei E; Zhang X; Jing X; Fu B; Wang G.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multi-institutional feasibility and safety outcomes of retroperitoneal robot-assisted partial nephrectomy in morbidly o…
Stout TE; McElree IM; Smith AC; Rac G; Patel H; Gupta G; Gellhaus PT.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Is cortisol an endogenous mediator of erectile dysfunction in the adult male?
Rahardjo HE; Becker AJ; Märker V; Kuczyk MA; Ückert S.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effect of target-controlled pressure-controlled ventilation on percutaneous nephrolithotripsy patients under general an…
Tao Y; Ma G; Sun T; Hu Y; Wang N; Ye Y; Zhao Z.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspe…
Fan X; He W; Huang J.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Urinary symptoms after genital gender-affirming penile construction, urethral lengthening and vaginectomy.
Fascelli M; Sajadi KP; Dugi DD; Dy GW.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A global, propensity-score matched analysis of patients receiving artificial urinary sphincters and the risk of complic…
Prebay ZJ; Ebbott D; Foss H; Li M; Chung PH.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Patient decision-making for surgical treatment of post-prostatectomy stress urinary incontinence: a mixed-methods explo…
Shaw NM; Nik-Ahd F; Jones C; Breyer BN; Walter LC; Sudore R; Cooperberg MR; Baussan C; Quanstrom K; Allen IE; Hampson LA.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Management of male stress urinary incontinence in high-risk patients: a narrative review.
Lin JS; Skokan AJ; Wessells H; Hagedorn JC.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison of early and delayed strategy for renal replacement therapy initiation for severe acute kidney injury with h…
Guo S; Chen Y; Huo Y; Zhao C; Zhang K; Zhang X; Liu M; Hu Z.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Significance of the FGFR3 mutation in Chinese patients with bladder cancer.
Hao L; Fang J; Xu R; Liu S; Luo G; Wang X.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Establishment and validation of a nomogram for predicting perioperative complications of retroperitoneal laparoscopic a…
He J; Zhao J; Luo Y; Wang Y; Li M; Wei D; Yang X; Hou Z; Jiang Y.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Regenerative therapies for erectile dysfunction: the influence of direct-to-consumer marketing on patient interest.
Yang SC; Weinberger JM; Shahinyan RH; Shahinyan GK; Mills JN; Eleswarapu SV.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
<i>MPP7</i> is a potential prognostic marker and is associated with cancer metabolism and immune infiltration in clear …
Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-re…
Qian C; Sun Y; Di S; Wang H; Tian Y; Wang C; Cui X.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma.
Zhou Y; Chen X; Li B; Li Y; Zhang B.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal c…
Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W.
Transl Androl Urol (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Sperm concentrations do not correlate with semen parameters and hormone profiles in males recovered from COVID-19.
Jiménez-López LA; Rojas-Ramírez DC; Martínez-Mier G; Pérez-López SD; Bernal-Dolores V; Reyes-Ruiz JM.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
5-alpha reductase inhibitors use in prostatic disease and beyond.
Chislett B; Chen D; Perera ML; Chung E; Bolton D; Qu LG.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The <i>en bloc</i> method is feasible for beginners learning to perform holmium laser enucleation of the prostate.
Wang X; Chen G; Wu P; Ben L; Liu Q; Wang J.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Research of targeted therapy for renal cancer from 2006 to 2022: a bibliometric and visualized analysis.
Gou Y; Fu Y; Li Y; Liu C.
Transl Androl Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared